{"id":"https://openalex.org/W2162361345","doi":null,"title":"Buprenorphine for office-based treatment of patients with opioid addiction.","display_name":"Buprenorphine for office-based treatment of patients with opioid addiction.","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2162361345","mag":"2162361345","pmid":"https://pubmed.ncbi.nlm.nih.gov/16118361"},"language":"en","primary_location":{"id":"pmid:16118361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16118361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the American Osteopathic Association","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065944066","display_name":"James J. Manlandro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"James J Manlandro","raw_affiliation_strings":["FAOAAM, FACOFP, 726 Petersburg Rd, PO Box 300, Dennisville, NJ 08214-0300, USA. drydoc80@aol.com","FAOAAM, FACOFP, 726 Petersburg Rd, PO Box 300, Dennisville, NJ 08214-0300, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAOAAM, FACOFP, 726 Petersburg Rd, PO Box 300, Dennisville, NJ 08214-0300, USA. drydoc80@aol.com","institution_ids":[]},{"raw_affiliation_string":"FAOAAM, FACOFP, 726 Petersburg Rd, PO Box 300, Dennisville, NJ 08214-0300, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065944066"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1045,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.79659619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"105","issue":"6 Suppl 3","first_page":"S8","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9160000085830688},{"id":"https://openalex.org/keywords/medication-assisted-treatment","display_name":"medication-assisted treatment","score":0.8479999899864197},{"id":"https://openalex.org/keywords/office-based-treatment","display_name":"office-based treatment","score":0.7860000133514404},{"id":"https://openalex.org/keywords/buprenorphine-naloxone","display_name":"buprenorphine/naloxone","score":0.9399999976158142},{"id":"https://openalex.org/keywords/methadone-clinics","display_name":"methadone clinics","score":0.8650000095367432},{"id":"https://openalex.org/keywords/opioid-prescribing","display_name":"opioid prescribing","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9223431348800659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8340363502502441},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.760295569896698},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.6953495740890503},{"id":"https://openalex.org/C169885649","wikidata":"https://www.wikidata.org/wiki/Q55190072","display_name":"Addiction medicine","level":3,"score":0.5910731554031372},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5450192093849182},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5038463473320007},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.4703787863254547},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3934965431690216},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32432860136032104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06526052951812744},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009819","descriptor_name":"Office Visits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:16118361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16118361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the American Osteopathic Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1979176060","https://openalex.org/W1988685120","https://openalex.org/W2007802571","https://openalex.org/W2027873427","https://openalex.org/W2033029518","https://openalex.org/W2046457014","https://openalex.org/W2053314566","https://openalex.org/W2054897163","https://openalex.org/W2088191781","https://openalex.org/W2092853006","https://openalex.org/W2098852732","https://openalex.org/W2147528480","https://openalex.org/W2151493975"],"related_works":["https://openalex.org/W2108082202","https://openalex.org/W17608643","https://openalex.org/W2113152002","https://openalex.org/W2044420094","https://openalex.org/W1983452093","https://openalex.org/W2155057413","https://openalex.org/W2000393144","https://openalex.org/W2270480675","https://openalex.org/W2115687136","https://openalex.org/W1972750503"],"abstract_inverted_index":{"The":[0,51,150,199,218],"Drug":[1,123],"Addiction":[2],"Treatment":[3,174,178],"Act":[4],"of":[5,19,28,33,73,107,170,175],"2000":[6],"(DATA":[7],"2000)":[8],"was":[9,40],"established":[10],"to":[11,36],"create":[12],"a":[13,79,215],"new":[14],"paradigm":[15],"for":[16,105,125,161,167,209],"medication-assisted":[17],"treatment":[18,46,89,106,130],"opiate":[20],"addiction":[21,39,109,129],"in":[22,43,78,152,172,204,235],"the":[23,31,87,118,119,146,168,173,205,223,227,232],"United":[24],"States.":[25],"Before":[26],"enactment":[27],"DATA":[29,74],"2000,":[30,75],"use":[32],"opioid":[34,38,88,103,108],"medications":[35,53,104,112],"treat":[37],"permissible":[41],"only":[42,52,66],"federally":[44],"approved":[45,116],"programs,":[47],"ie,":[48],"methadone":[49,60,136],"clinics.":[50,137],"permitted":[54],"were":[55,132],"Schedule":[56,98],"II":[57],"drugs":[58],"(eg,":[59],"and":[61,82,101,122,145,193,226],"l-a-acetylmethadol":[62],"[LAAM]),":[63],"which":[64],"could":[65],"be":[67],"dispensed,":[68],"not":[69],"prescribed.":[70],"Under":[71],"provisions":[72],"qualified":[76],"physicians":[77],"medical":[80],"office":[81],"other":[83],"appropriate":[84],"settings":[85],"outside":[86],"program":[90],"system":[91],"may":[92,140],"prescribe":[93],"or":[94],"dispense":[95,142],"(or":[96],"both),":[97],"III,":[99],"IV,":[100],"V":[102],"if":[110],"such":[111],"have":[113],"been":[114],"specifically":[115],"by":[117],"US":[120],"Food":[121],"Administration":[124],"that":[126,230],"indication.":[127],"Opioid":[128,176],"programs":[131],"commonly":[133],"known":[134],"as":[135,212],"They":[138],"now":[139],"also":[141],"buprenorphine":[143,147],"hydrochloride":[144],"hydrochloride-naloxone":[148],"combination.":[149],"information":[151],"this":[153],"article":[154],"is":[155,203],"extracted":[156],"(with":[157],"revision)":[158],"from:":[159],"Center":[160],"Substance":[162,191],"Abuse":[163,192],"Treatment.":[164],"Clinical":[165,200],"Guidelines":[166,201],"Use":[169],"Buprenorphine":[171],"Addiction.":[177],"Improvement":[179],"Protocol":[180],"(TIP)":[181],"Series":[182],"40.":[183],"DHS":[184],"Publication":[185],"No.":[186],"(SMA)":[187],"04-3939.":[188],"Rockville,":[189],"Md:":[190],"Mental":[194],"Health":[195],"Services":[196],"Administration;":[197],"2004.":[198],"document":[202,237],"public":[206],"domain":[207],"except":[208],"material":[210],"indicated":[211],"reprinted":[213],"from":[214],"copyrighted":[216],"source.":[217],"author":[219],"served":[220],"on":[221],"both":[222],"Expert":[224],"Panel":[225,229],"Consensus":[228],"produced":[231],"guidelines,":[233],"available":[234],"portable":[236],"format":[238],"at":[239],"http://buprenorphine.samhsa.gov/Bup%20Guidelines.pdf.":[240]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}